Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)DivestmentsExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neogen (NEOG) Non-cash Items (2010 - 2025)

Neogen's quarterly Non-cash Items came in at $113000.0 in Q2 2025, up 105.45% year-on-year from $55000.0 in Q2 2024, and up 105.45% quarter-over-quarter from $55000.0 in Q2 2024.

Neogen has reported Non-cash Items for 15 years, with the latest figure at $113000.0 in Q2 2025.

  • For the quarter ending Q2 2025, Non-cash Items rose 105.45% year-over-year to $113000.0; the trailing twelve-month figure through May 2025 stood at $113000.0 (up 105.45% YoY), and the FY2025 full-year result was $113000.0, up 105.45% from the prior year.
  • Non-cash Items for Q2 2025 stood at $113000.0, up from $55000.0 in the prior quarter.
  • The five-year high for Non-cash Items was $6.2 million in Q2 2023, with the low at $55000.0 in Q2 2024.
  • Average Non-cash Items over 5 years is $1.6 million, with a median of $643000.0 recorded in 2021.
  • Year-over-year, Non-cash Items soared 416.71% in 2023 and plunged 99.11% in 2024.
  • Tracing NEOG's Non-cash Items over 5 years: stood at $643000.0 in 2021, then jumped by 85.23% to $1.2 million in 2022, then soared by 416.71% to $6.2 million in 2023, then sank by 99.11% to $55000.0 in 2024, then soared by 105.45% to $113000.0 in 2025.
  • The last three Non-cash Items figures came in at $113000.0 (Q2 2025), $55000.0 (Q2 2024), and $6.2 million (Q2 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Neogen 1.94 Bn 1.78 Bn 99.00 Mn

Historic Data

Download Data 🔒
DateValue
May 31, 2025 113,000.00
May 31, 2025 113,000.00
May 31, 2024 55,000.00
May 31, 2024 55,000.00
May 31, 2023 6.15 Mn
May 31, 2023 6.15 Mn
May 31, 2022 1.19 Mn
May 31, 2022 1.19 Mn
May 31, 2021 643,000.00
May 31, 2021 643,000.00
May 31, 2020 972,000.00
May 31, 2020 972,000.00
May 31, 2018 508,000.00
May 31, 2018 508,000.00
May 31, 2017 39.39 Mn
May 31, 2017 39.39 Mn
May 31, 2016 26.34 Mn
May 31, 2016 26.34 Mn
May 31, 2015 852,000.00
May 31, 2015 852,000.00
May 31, 2014 577,000.00
May 31, 2014 577,000.00
May 31, 2013 749,000.00
May 31, 2013 749,000.00
May 31, 2012 863,000.00
May 31, 2012 863,000.00
May 31, 2011 764,000.00
May 31, 2011 764,000.00
May 31, 2010 729,000.00
May 31, 2010 729,000.00